These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20166953)

  • 1. Calpains: attractive targets for the development of synthetic inhibitors.
    Pietsch M; Chua KC; Abell AD
    Curr Top Med Chem; 2010; 10(3):270-93. PubMed ID: 20166953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational Design of Calpain Inhibitors Based on Calpastatin Peptidomimetics.
    Low KE; Ler S; Chen KJ; Campbell RL; Hickey JL; Tan J; Scully CC; Davies PL; Yudin AK; Zaretsky S
    J Med Chem; 2016 Jun; 59(11):5403-15. PubMed ID: 27148623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design of allosteric calpain-1 inhibitors populating a novel bioactivity space.
    Kalash L; Cresser-Brown J; Habchi J; Morgan C; Miller DJ; Glen RC; Allemann RK; Bender A
    Eur J Med Chem; 2018 Sep; 157():1264-1275. PubMed ID: 30195237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulators of calpain activity: inhibitors and activators as potential drugs.
    Dókus LE; Yousef M; Bánóczi Z
    Expert Opin Drug Discov; 2020 Apr; 15(4):471-486. PubMed ID: 32022614
    [No Abstract]   [Full Text] [Related]  

  • 5. A new cell-permeable calpain inhibitor.
    Fiorino F; Gil-Parrado S; Assfalg-Machleidt I; Machleidt W; Moroder L
    J Pept Sci; 2007 Jan; 13(1):70-3. PubMed ID: 17019744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developments in the design and synthesis of calpain inhibitors.
    Neffe AT; Abell AD
    Curr Opin Drug Discov Devel; 2005 Nov; 8(6):684-700. PubMed ID: 16312145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography.
    Cuerrier D; Moldoveanu T; Inoue J; Davies PL; Campbell RL
    Biochemistry; 2006 Jun; 45(24):7446-52. PubMed ID: 16768440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin.
    Hanna RA; Campbell RL; Davies PL
    Nature; 2008 Nov; 456(7220):409-12. PubMed ID: 19020623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamic simulations of the catalytic subunit of calpains 1, 2, 5, and 10: Structural analysis with an aim toward drug design.
    Romo-Mancillas A; Lemus R; Pérez-Estrada R; Kuribreña-Romero de Terreros F; Domínguez-Ramírez L
    Chem Biol Drug Des; 2019 Jan; 93(1):38-49. PubMed ID: 30107087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New tripeptide-based macrocyclic calpain inhibitors formed by N-alkylation of histidine.
    Chen H; Jiao W; Jones MA; Coxon JM; Morton JD; Bickerstaffe R; Pehere AD; Zvarec O; Abell AD
    Chem Biodivers; 2012 Nov; 9(11):2473-84. PubMed ID: 23161629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A structural model for the inhibition of calpain by calpastatin: crystal structures of the native domain VI of calpain and its complexes with calpastatin peptide and a small molecule inhibitor.
    Todd B; Moore D; Deivanayagam CC; Lin GD; Chattopadhyay D; Maki M; Wang KK; Narayana SV
    J Mol Biol; 2003 Apr; 328(1):131-46. PubMed ID: 12684003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calpain and calpastatin].
    Murachi T
    Rinsho Byori; 1990 Apr; 38(4):337-46. PubMed ID: 2195187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of calpain-specific inactivators by screening of positional scanning epoxide libraries.
    Cuerrier D; Moldoveanu T; Campbell RL; Kelly J; Yoruk B; Verhelst SHL; Greenbaum D; Bogyo M; Davies PL
    J Biol Chem; 2007 Mar; 282(13):9600-9611. PubMed ID: 17218315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calpain inhibition: a therapeutic strategy targeting multiple disease states.
    Carragher NO
    Curr Pharm Des; 2006; 12(5):615-38. PubMed ID: 16472152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of calpain-E64 and -leupeptin inhibitor complexes reveal mobile loops gating the active site.
    Moldoveanu T; Campbell RL; Cuerrier D; Davies PL
    J Mol Biol; 2004 Nov; 343(5):1313-26. PubMed ID: 15491615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing of primed and unprimed sites of calpains: Design, synthesis and evaluation of epoxysuccinyl-peptide derivatives as selective inhibitors.
    Dókus LE; Menyhárd DK; Tantos Á; Hudecz F; Bánóczi Z
    Eur J Med Chem; 2014 Jul; 82():274-80. PubMed ID: 24915003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation and molecular modelling of N-heterocyclic dipeptide aldehydes as selective calpain inhibitors.
    Jones MA; Morton JD; Coxon JM; McNabb SB; Lee HY; Aitken SG; Mehrtens JM; Robertson LJ; Neffe AT; Miyamoto S; Bickerstaffe R; Gately K; Wood JM; Abell AD
    Bioorg Med Chem; 2008 Jul; 16(14):6911-23. PubMed ID: 18571418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolytic processing of nuclear factor kappa B by calpain in vitro.
    Liu ZQ; Kunimatsu M; Yang JP; Ozaki Y; Sasaki M; Okamoto T
    FEBS Lett; 1996 Apr; 385(1-2):109-13. PubMed ID: 8641452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calpains (intracellular calcium-activated cysteine proteinases): structure-activity relationships and involvement in normal and abnormal cellular metabolism.
    Johnson P
    Int J Biochem; 1990; 22(8):811-22. PubMed ID: 2279616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity profile of calpains I and II in chronically infarcted rat myocardium--influence of the calpain inhibitor CAL 9961.
    Sandmann S; Prenzel F; Shaw L; Schauer R; Unger T
    Br J Pharmacol; 2002 Apr; 135(8):1951-8. PubMed ID: 11959798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.